UBS Asset Management Americas Inc. Sells 756 Shares of Plexus Corp. (NASDAQ:PLXS)

UBS Asset Management Americas Inc. lessened its position in shares of Plexus Corp. (NASDAQ:PLXS) by 2.4% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,320 shares of the technology company’s stock after selling 756 shares during the period. UBS Asset Management Americas Inc. owned approximately 0.11% of Plexus worth $1,828,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the company. Oregon Public Employees Retirement Fund boosted its position in Plexus by 1.6% during the second quarter. Oregon Public Employees Retirement Fund now owns 12,386 shares of the technology company’s stock valued at $723,000 after acquiring an additional 200 shares during the last quarter. Swiss National Bank boosted its position in Plexus by 0.9% during the second quarter. Swiss National Bank now owns 57,500 shares of the technology company’s stock valued at $3,356,000 after acquiring an additional 500 shares during the last quarter. D. E. Shaw & Co. Inc. boosted its position in Plexus by 0.9% during the second quarter. D. E. Shaw & Co. Inc. now owns 63,220 shares of the technology company’s stock valued at $3,690,000 after acquiring an additional 560 shares during the last quarter. Holocene Advisors LP boosted its position in Plexus by 5.4% during the second quarter. Holocene Advisors LP now owns 11,692 shares of the technology company’s stock valued at $682,000 after acquiring an additional 603 shares during the last quarter. Finally, Envestnet Asset Management Inc. boosted its position in Plexus by 6.7% during the second quarter. Envestnet Asset Management Inc. now owns 22,663 shares of the technology company’s stock valued at $1,323,000 after acquiring an additional 1,416 shares during the last quarter. Institutional investors own 95.38% of the company’s stock.

PLXS stock opened at $63.31 on Friday. The stock has a market capitalization of $1.80 billion, a PE ratio of 19.60 and a beta of 0.96. The company’s 50-day moving average is $60.75 and its 200-day moving average is $58.70. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.78 and a quick ratio of 0.91. Plexus Corp. has a 1 year low of $47.63 and a 1 year high of $66.98.

Plexus (NASDAQ:PLXS) last released its quarterly earnings data on Wednesday, July 17th. The technology company reported $0.81 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.81. The company had revenue of $799.64 million for the quarter, compared to analysts’ expectations of $783.30 million. Plexus had a net margin of 4.62% and a return on equity of 12.40%. The business’s revenue was up 10.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.79 EPS. On average, analysts anticipate that Plexus Corp. will post 3.37 earnings per share for the current fiscal year.

In related news, Chairman Dean A. Foate sold 6,832 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $63.00, for a total value of $430,416.00. Following the sale, the chairman now owns 227,921 shares in the company, valued at approximately $14,359,023. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Stephen P. Cortinovis sold 5,000 shares of the company’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $60.15, for a total transaction of $300,750.00. The disclosure for this sale can be found here. Insiders sold a total of 28,980 shares of company stock worth $1,737,525 in the last 90 days. 3.90% of the stock is currently owned by company insiders.

PLXS has been the topic of a number of research analyst reports. Zacks Investment Research raised shares of Plexus from a “sell” rating to a “hold” rating and set a $60.00 price objective on the stock in a research report on Monday, September 2nd. Sidoti set a $72.00 price objective on shares of Plexus and gave the stock a “buy” rating in a research report on Friday, June 14th. Finally, BidaskClub cut shares of Plexus from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 28th.

Plexus Profile

Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers design and development, supply chain, new product introduction, and manufacturing solutions, as well as aftermarket services. The company provides its solutions to companies in the healthcare and life sciences, industrial and commercial, communications, and aerospace and defense sectors.

Featured Story: How to find the components of the quick ratio

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.